Novo Nordisk officials say the new formulation delivers the same efficacy and safety profile as the originally approved formulation, but at a lower dose
While it is primarily used to treat growth hormone deficiency, some adults may benefit from Sermorelin if they have clinically low growth hormone levels, which can affect metabolism, energy, and body composition
The newer Foundayo (orforglipron), FDA approved April 2026, is the first oral GLP-1 with no food or water restrictions although average weight loss is lower than the injectables (11% vs 15-20%)
A patient who is pregnant, planning pregnancy, or becomes pregnant while receiving treatment should speak with the prescribing clinician promptly
It is a Growth Hormone Releasing Hormone (GHRH) analog it goes straight to your pituitary gland and tells it to stop being lazy and start producing natural Growth Hormone